» Articles » PMID: 35336056

Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Mar 26
PMID 35336056
Authors
Affiliations
Soon will be listed here.
Abstract

The increased demand for physiologically relevant in vitro human skin models for testing pharmaceutical drugs has led to significant advancements in skin engineering. One of the most promising approaches is the use of in vitro microfluidic systems to generate advanced skin models, commonly known as skin-on-a-chip (SoC) devices. These devices allow the simulation of key mechanical, functional and structural features of the human skin, better mimicking the native microenvironment. Importantly, contrary to conventional cell culture techniques, SoC devices can perfuse the skin tissue, either by the inclusion of perfusable lumens or by the use of microfluidic channels acting as engineered vasculature. Moreover, integrating sensors on the SoC device allows real-time, non-destructive monitoring of skin function and the effect of topically and systemically applied drugs. In this Review, the major challenges and key prerequisites for the creation of physiologically relevant SoC devices for drug testing are considered. Technical (e.g., SoC fabrication and sensor integration) and biological (e.g., cell sourcing and scaffold materials) aspects are discussed. Recent advancements in SoC devices are here presented, and their main achievements and drawbacks are compared and discussed. Finally, this review highlights the current challenges that need to be overcome for the clinical translation of SoC devices.

Citing Articles

3D Models Currently Proposed to Investigate Human Skin Aging and Explore Preventive and Reparative Approaches: A Descriptive Review.

Lombardi F, Augello F, Ciafarone A, Ciummo V, Altamura S, Cinque B Biomolecules. 2024; 14(9).

PMID: 39334833 PMC: 11430810. DOI: 10.3390/biom14091066.


Revolutionizing Drug Discovery: The Impact of Distinct Designs and Biosensor Integration in Microfluidics-Based Organ-on-a-Chip Technology.

Yuan S, Yuan H, Hay D, Hu H, Wang C Biosensors (Basel). 2024; 14(9).

PMID: 39329800 PMC: 11430660. DOI: 10.3390/bios14090425.


Organs on chips: fundamentals, bioengineering and applications.

Awad N J Artif Organs. 2024; .

PMID: 39134691 DOI: 10.1007/s10047-024-01460-0.


Progress in Topical and Transdermal Drug Delivery Research-Focus on Nanoformulations.

Lunter D, Klang V, Eichner A, Savic S, Savic S, Lian G Pharmaceutics. 2024; 16(6).

PMID: 38931938 PMC: 11207871. DOI: 10.3390/pharmaceutics16060817.


Recombinant Human Keratinocyte Growth Factor Ameliorates Cancer Treatment-Induced Oral Mucositis on a Chip.

Ly K, Rajtboriraks M, Elgerbi A, Luo X, Raub C Adv Healthc Mater. 2024; 13(14):e2302970.

PMID: 38351394 PMC: 11144107. DOI: 10.1002/adhm.202302970.


References
1.
Thompson C, Fu S, Knight M, Thorpe S . Mechanical Stimulation: A Crucial Element of Organ-on-Chip Models. Front Bioeng Biotechnol. 2020; 8:602646. PMC: 7758201. DOI: 10.3389/fbioe.2020.602646. View

2.
Agarwal T, Narayana G, Banerjee I . Keratinocytes are mechanoresponsive to the microflow-induced shear stress. Cytoskeleton (Hoboken). 2019; 76(2):209-218. DOI: 10.1002/cm.21521. View

3.
Korkmaz E, Balmert S, Sumpter T, Donahue Carey C, Erdos G, Falo Jr L . Microarray patches enable the development of skin-targeted vaccines against COVID-19. Adv Drug Deliv Rev. 2021; 171:164-186. PMC: 8060128. DOI: 10.1016/j.addr.2021.01.022. View

4.
Lee M, Choi J, Eom M, Jeong E, Kim J, Park S . Prevascularized Tracheal Scaffolds Using the Platysma Flap for Enhanced Tracheal Regeneration. Laryngoscope. 2020; 131(8):1732-1740. DOI: 10.1002/lary.29178. View

5.
Sivarapatna A, Ghaedi M, Xiao Y, Han E, Aryal B, Zhou J . Engineered Microvasculature in PDMS Networks Using Endothelial Cells Derived from Human Induced Pluripotent Stem Cells. Cell Transplant. 2017; 26(8):1365-1379. PMC: 5680973. DOI: 10.1177/0963689717720282. View